Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease

被引:57
|
作者
Roy, Bidisha [1 ]
Jackson, George R. [2 ,3 ,4 ]
机构
[1] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA
[2] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA
[3] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA
[4] Michael E DeBakey VA Med Ctr, Parkinsons Dis Res Educ & Clin Ctr, Houston, TX 77030 USA
关键词
MICROTUBULE-ASSOCIATED PROTEINS; REGULATES SYNAPTIC GROWTH; LEWY BODY PATHOLOGY; ALZHEIMERS-DISEASE; IN-VITRO; NEUROMUSCULAR-JUNCTION; INCREASED EXPRESSION; AXONAL-TRANSPORT; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES;
D O I
10.1093/hmg/ddu011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Clinical and pathological studies have suggested considerable overlap between tauopathies and synucleinopathies. Several genome-wide association studies have identified alpha-Synuclein (SNCA) and Tau (MAPT) polymorphisms as common risk factors for sporadic Parkinson's disease (PD). However, the mechanisms by which subtle variations in the expression of wild-type SNCA and MAPT influence risk for PD and the underlying cellular events that effect neurotoxicity remain unclear. To examine causes of neurotoxicity associated with the alpha-Syn/Tau interaction, we used the fruit fly as a model. We utilized misexpression paradigms in three different tissues to probe the alpha-Syn/Tau interaction: the retina, dopaminergic neurons and the larval neuromuscular junction. Misexpression of Tau and alpha-Syn enhanced a rough eye phenotype and loss of dopaminergic neurons in fly tauopathy and synucleinopathy models, respectively. Our findings suggest that interactions between alpha-Syn and Tau at the cellular level cause disruption of cytoskeletal organization, axonal transport defects and aberrant synaptic organization that contribute to neuronal dysfunction and death associated with sporadic PD. alpha-Syn did not alter levels of Tau phosphorylated at the AT8 epitope. However, alpha-Syn and Tau colocalized in ubiquitin-positive aggregates in eye imaginal discs. The presence of Tau also led to an increase in urea soluble alpha-Syn. Our findings have important implications in understanding the cellular and molecular mechanisms underlying alpha-Syn/Tau-mediated synaptic dysfunction, which likely arise in the early asymptomatic phase of sporadic PD.
引用
收藏
页码:3008 / 3023
页数:16
相关论文
共 50 条
  • [21] Tau accelerates α-synuclein aggregation and spreading in Parkinson's disease
    Pan, Lina
    Li, Chunrui
    Meng, Lanxia
    Tian, Ye
    He, Mingyang
    Yuan, Xin
    Zhang, Guoxin
    Zhang, Zhaohui
    Xiong, Jing
    Chen, Guiqin
    Zhang, Zhentao
    [J]. BRAIN, 2022, 145 (10) : 3454 - 3471
  • [22] Neurotoxicity by Hypoxia an Intermediate Between Alpha-synuclein and Mitochondrial Dysfunction in Parkinson's Disease
    Chand, Jagdish
    Fanai, Hannah Lalengzuali
    Antony, A. S.
    Subramanian, Gomathy
    [J]. JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS, 2024, 15 (03) : 253 - 263
  • [23] Review on the interactions between dopamine metabolites and ?-Synuclein in causing Parkinson?s disease
    Sivakumar, P.
    Nagashanmugam, K. B.
    Priyatharshni, S.
    Lavanya, R.
    Prabhu, N.
    Ponnusamy, S.
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2023, 162
  • [24] Copper oxide nanoparticles promote α-synuclein oligomerization and underlying neurotoxicity as a model of Parkinson's disease
    Lyu, Jingjun
    Long, Xiaobing
    Xie, Tuxiu
    Jiang, Guijun
    Jiang, Jie
    Ye, Lu
    Li, Qiongzi
    [J]. JOURNAL OF MOLECULAR LIQUIDS, 2021, 323
  • [25] Effect of membranes on alpha synuclein oligomerization and neurotoxicity in Parkinson's 's disease
    Ysselstein, D.
    Joshi, M.
    Mishra, V. R.
    Griggs, A. M.
    Post, C. B.
    Rochet, J. -C.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S39 - S40
  • [26] α-Synuclein: Membrane Interactions and Toxicity in Parkinson's Disease
    Auluck, Pavan K.
    Caraveo, Gabriela
    Lindquist, Susan
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 26, 2010, 26 : 211 - 233
  • [27] PARKINSON'S DISEASE DEMENTIA: AT THE CROSSROADS OF α-SYNUCLEIN, TAU AND AMYLOID-β
    Irwin, David
    Lee, V.
    Trojanowski, J.
    [J]. NEUROBIOLOGY OF AGING, 2014, 35 : S11 - S11
  • [28] α-synuclein immunization in a model of Parkinson's disease
    不详
    [J]. NEUROSCIENTIST, 2005, 11 (06): : 523 - 523
  • [29] Human HtrA2 functions differently from drosophila HtrA2 in the detoxification of α-synuclein-induced neurotoxicity in a drosophila model of Parkinson's disease
    Rahman, M. M.
    Akhter, S.
    Islam, M. S.
    Kim, H. -J.
    Hong, S. -T.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S222 - S222
  • [30] A Drosophila model of Parkinson's disease
    Feany, MB
    Bender, WW
    [J]. NATURE, 2000, 404 (6776) : 394 - 398